Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients-Reference-Cited by-同舟云学术

Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients

Published:2017-04-10 Issue:4 Volume:35 Page:436-441
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Heidelberger Valentine,Goldwasser François,Kramkimel Nora,Jouinot Anne,Huillard Olivier,Boudou-Rouquette Pascaline,Chanal Johan,Arrondeau Jennifer,Franck Nathalie,Alexandre Jérôme,Blanchet Benoît,Leroy Karen,Avril Marie-Françoise,Dupin Nicolas,Aractingi Sélim

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/article/10.1007/s10637-017-0464-x/fulltext.html

Reference24 articles.

1. Ribas A, Puzanov I, Dummer R et al (2015) Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. Lancet Oncol 16:908–918. doi: 10.1016/S1470-2045(15)00083-2

2. Robert C, Schachter J, Long GV et al (2015) Pembrolizumab versus Ipilimumab in Advanced Melanoma. N Engl J Med 372:2521–2532. doi: 10.1056/NEJMoa1503093

3. Robert C, Long GV, Brady B et al (2015) Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372:320–330. doi: 10.1056/NEJMoa1412082

4. Weber JS, D’Angelo SP, Minor D et al (2015) Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol 16:375–384. doi: 10.1016/S1470-2045(15)70076-8

5. Huillard O, Mir O, Peyromaure M et al (2013) Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. Br J Cancer 108:1034–1041. doi: 10.1038/bjc.2013.58

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Die Bedeutung von Sarkopenie für die immunvermittelte Toxizität bei Patienten mit malignem Melanom unter einer Immuncheckpoint-Inhibition;Die Dermatologie;2024-08-14

2. Sarcopenic obesity in cancer;Radiology and Oncology;2024-02-21

3. Antibody Drug Clearance: An Underexplored Marker of Outcomes with Checkpoint Inhibitors;Clinical Cancer Research;2023-12-13

4. Prognostic value of body composition on survival outcomes in melanoma patients receiving immunotherapy;Frontiers in Immunology;2023-11-22

5. Subcutaneous Fat Abundance and Density Are Associated with an Enhanced Response to Immunotherapy in Metastatic Melanoma: A Retrospective Cohort Study;Academic Radiology;2023-09